Tuesday, April 14, 2015 11:56:43 PM
VTEQ ~ "FDA CLEARED" - Amount Beneficially Owned: 1,679,787
(b)Percent of Class: 5.5% based on 30,802,114 shares of common stock outstanding as of March 31, 2015
DELRAY BEACH, Fla., April 13, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has expanded its intellectual property portfolio with a patent filing in Brazil for its high-temperature Q Inside Safety Technology micro-transponder.
http://finance.yahoo.com/news/veriteq-corporation-expands-intellectual-property-123000685.html
VeriTeQ would exclusively license its intellectual property, safety data test and FDA file reference, and business opportunities related to its Q Inside Safety Technology for the breast implant market to EL, and EL would pay an upfront license fee of $1.75 million. EL would also have a 24-month option to purchase VeriTeQ's Q Inside Safety Technology business for the breast implant market for $10 million
http://finance.yahoo.com/news/veriteq-corporation-executes-term-sheet-133000890.html
February 5, 2015 10:25 AM
GlobeNewswire
DELRAY BEACH, Fla., Feb. 5, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ" or "Company") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, today commented on this morning's Today Show segment entitled "Company implants microchips in employees." The segment represents that RF (radio frequency) access applications are new or first of a kind. This is not accurate. Specifically, years ago, VeriTeQ's predecessors, VeriChip Corporation/Applied Digital Solutions, received FDA clearance in 2004 to use an implantable RF micro-transponder to access medical records in an emergency or clinical application. One of VeriChip's other applications was building / office access
http://finance.yahoo.com/news/veriteq-corporation-comments-mornings-today-152522604.html
CHART
(b)Percent of Class: 5.5% based on 30,802,114 shares of common stock outstanding as of March 31, 2015
DELRAY BEACH, Fla., April 13, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has expanded its intellectual property portfolio with a patent filing in Brazil for its high-temperature Q Inside Safety Technology micro-transponder.
http://finance.yahoo.com/news/veriteq-corporation-expands-intellectual-property-123000685.html
VeriTeQ would exclusively license its intellectual property, safety data test and FDA file reference, and business opportunities related to its Q Inside Safety Technology for the breast implant market to EL, and EL would pay an upfront license fee of $1.75 million. EL would also have a 24-month option to purchase VeriTeQ's Q Inside Safety Technology business for the breast implant market for $10 million
http://finance.yahoo.com/news/veriteq-corporation-executes-term-sheet-133000890.html
February 5, 2015 10:25 AM
GlobeNewswire
DELRAY BEACH, Fla., Feb. 5, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ" or "Company") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, today commented on this morning's Today Show segment entitled "Company implants microchips in employees." The segment represents that RF (radio frequency) access applications are new or first of a kind. This is not accurate. Specifically, years ago, VeriTeQ's predecessors, VeriChip Corporation/Applied Digital Solutions, received FDA clearance in 2004 to use an implantable RF micro-transponder to access medical records in an emergency or clinical application. One of VeriChip's other applications was building / office access
http://finance.yahoo.com/news/veriteq-corporation-comments-mornings-today-152522604.html
CHART
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
